Influenza: Recommended vaccinations
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 
Vaccination not funded by the National Health system
 
Mandatory vaccination
MonthsYears
623235671217184550555960≥ 65
Austria
IIV4/LAIV
IIV4/aIIV4/QIV-HD1
Belgium
IIV4
IIV4/QIV-HD2
Bulgaria
IIV3/IIV4/LAIV3
IIV3/IIV44
Croatia
IIV45
IIV4
Cyprus
IIV46
aIIV4
Czechia
IIV4/LAIV7
IIV4/QIV-HD8
Denmark
IIV49
Estonia
IIV410
IIV4
Finland
IIV4/LAIV11
IIV4
France
IIV4
IIV4
Germany
IIV412
IIV4/QIV-HD13
Greece
IIV314
IIV4/aIIV4/QIV-HD15
Hungary
IIV416
IIV3
Iceland
IIV4
IIV417
Ireland
IIV4/LAIV18
IIV419
Italy
LAIV/IIV3/cIIV320
aIIV3/TIV-HD/IIV3
Latvia
IIV4/LAIV
IIV4/LAIV21
QIV-HD
Liechtenstein
IIV422
IIV423
Lithuania
IIV424
IIV425
Luxembourg
IIV4
Malta
IIV4
IIV4
Netherlands
IIV426
Norway
IIV3/aIIV3
Poland
IIV4
IIV4/QIV-HD27
Portugal
IIV4/QIV-HD28
Romania
IIV3/IIV4/LAIV
IIV3/IIV4/QIV-HD29
Slovakia
IIV4/LAIV30
IIV4
Slovenia
IIV431
IIV4
Spain
IIV4/cIIV4/LAIV
IIV4/aIIV4/cIIV4/QIV-HD
Sweden
IIV4/LAIV
IIV4

Footnotes:

  1. QIV-HD (not funded). More information: https://impfen.gv.at/impfungen/influenza
  2. Partially funded. In part of the country (Flanders), the vaccine is provided and administered entirely free of charge for residents of nursing homes.
  3. Inactivated vaccines are recommended for children over 6 months of age. LAIV is recommended for children over 24 months of age. Vaccines are not funded but vaccine administration is funded by the national health insurance.
  4. Inactivated vaccines are recommended for all people over 18 years of age. Vaccines are not funded but vaccine administration is funded by the national health insurance only for insured. For people over 65 years of age vaccines and administration are free according to the national programme. Free of charge for those aged 65 years and above until the 2023–26 influenza season
  5. Children and adolescents that are not at risk can get the influenza vaccine from six months old but it is not funded. Vaccination is recommended and funded by Croatian Health Insurance for all children at risk.
  6. The vaccine can be given as a specific recommendation for individuals six months to 17 years old with a chronic medical condition. https://www.gov.cy/moh/en/national-vaccination-advisory-committee/
  7. Universal recommendation is given for all age groups but children from six months to five years old belong to the high-risk group. For more information: https://vakcinace.eu/doporuceni-a-stanoviska/doporuceni-ceske-vakcinologicke-spolecnosti-cls-jep-k-ockovani-proti-chripce-4
  8. For individuals below 65 years old, funding is only for specified patients with risk conditions on treatment and is funded for IIV4. QIV-HD is funded for whole population over 65 years old. More information: https://vakcinace.eu/doporuceni-a-stanoviska/doporuceni-ceske-vakcinologicke-spolecnosti-cls-jep-k-ockovani-proti-chripce-4
  9. In children, there is no general recommendation, only for certain risk groups.
  10. Vaccination is free for the following groups: residents of welfare institutions, people aged 60 years and older, children aged six months to seven years old, pregnant women, children and adolescents 7–17 years old who have an increased risk of becoming seriously ill due to their health condition (heart and blood vessel diseases, oncological diseases, immunodeficiency, diabetes and obstructive lung disease).
  11. more information: https://thl.fi/en/topics/infectious-diseases-and-vaccinations/information-about-vaccinations/vaccination-programme-for-children-and-adults
  12. Children/adolescence between the age of 6 month and 17 years with one or more medical condition or underlying disease, are recommended to receive seasonal influenza vaccination. Medical conditions or underlying diseases to consider are: -Chronic diseases of the respiratory tract, including asthma and chronic obstructive pulmonary disease (COPD) -Chronic cardiovascular, liver and kidney disease -Diabetes mellitus and other metabolic diseases -Chronic neurological diseases, e. g., multiple sclerosis with relapses triggered by infections -Congenital or acquired immunodeficiency -HIV infection More information is available at: https://www.rki.de/DE/Aktuelles/Publikationen/Epidemiologisches-Bulletin/2024/04_24.pdf?__blob=publicationFile&v=4
  13. For more information: https://www.rki.de/EN/Topics/Infectious-diseases/Immunisation/STIKO/STIKO-recommendations/recommendations_content.html
  14. Since 2024 flu vaccination is recommended to all children between 6 months -5 years of age. In addition, Greece has recommendations for children and adolescents belonging to high-risk groups. Source: https://www.moh.gov.gr/articles/health/dieythynsh-dhmosias-ygieinhs/emboliasmoi/ethniko-programma-emboliasmwn-epe-paidiwn-kai-efhbwn
  15. QIV-HD and aIIV4 recommended in adults aged =65 years.
  16. Hungary’s recommendation is for children 6–35 months old with chronic pulmonary, cardiovascular, renal or hepatic disease, metabolic disorders or immunosuppression due to disease or treatment
  17. Annual vaccination (IIV4 introduced in 2020 to replace IIV3)
  18. LAIV is recommended and funded for 24 months to <18 years. IIV4 was also recommended and funded for children aged >6 months to 17 years with medical conditions in 2024-25 influenza season.
  19. The national influenza programme was funded for those aged 60 years in 2024-25 influenza season. Influenza vaccine was also recommended for those aged 50-59 but not funded for vaccine and its administration.
  20. Vaccination is offered free of charge to all children from six months to six years old. From six months onwards, vaccination is offered free of charge to all people with chronic medical conditions
  21. The vaccine is recommended for children and adolescents aged 24 months to 17 years with chronic lung or cardiovascular diseases, chronic metabolic or kidney conditions or immunodeficiency, as well as those receiving immunosuppressive therapy or long-term acetylsalicylic acid therapy. https://www.spkc.gov.lv/lv/vakcinacija#valsts-apmaksata-vakcinacija-pret-gripu
  22. For 6 months to 8 years, vaccination is not recommended for healthy children but is recommended for premature babies (born before gestational week 33 (e.g. <32 weeks and seven days of pregnancy) or with a birth weight of less than 1 500g) from the age of six months and for the first two winters after birth. For 6 months to 18 years, vaccination is recommended for children and adolescents with chronic medical conditions.
  23. For individuals aged >=18 years, the recommended influenza vaccines are Vaxigrip Tetra®, Fluarix Tetra®, Influvac Tetra®, and Flucelvax Tetra®. The same vaccines (Vaxigrip Tetra®, Fluarix Tetra®, Influvac Tetra®, Flucelvax Tetra®) are also recommended for those aged >=50, >=55, >=59, and >=60 years. For individuals aged >=65 years, the recommended vaccine is Efluelda®.
  24. Universal recommendation for all age groups. Funding for risk groups: 24 months to seven years old (included in the Lithuanian immunisation schedule from 12 February 2024, starting with the 2024–2025 season) and from six months to under18 years old with chronic medical conditions.
  25. Universal recommendation for all age groups. Funding only for those over 65 years old (included in the immunisation schedule).
  26. https://www.rivm.nl/en/flu-and-flu-jab
  27. The vaccine and its administration are partially funded (50%). QIV-HD in adults aged 60 years and above. https://szczepienia.pzh.gov.pl/szczepionki/grypa/?strona=9#jak-refundowane-sa-szczepionki-przeciw-grypie-w-sezonie-2024/2025
  28. QIV-HD is funded for people aged 85 years and older. More information: https://www.dgs.pt/normas-orientacoes-e-informacoes/normas-e-circulares-normativas/norma-n-072024-de-04092024-atualizada-a-07032025-campanha-de-vacinacao-sazonal-contra-a-gripe-outono-inverno-2024-2025-.aspx
  29. For adults aged 45–65 years without chronic medical conditions, the influenza vaccines are 50% reimbursed. For those aged 65 years and above the vaccine is fully reimbursed.
  30. Vaccination against influenza is supported by the legislation for children 6 months – 12 years, individuals with specified chronic medical conditions, older adults aged 59 years and above and people accommodated in long-term facilities. However, the vaccination is generally recommended and fully funded to the whole population in every influenza season.
  31. Vaccination is also recommended for the specific risk groups (children aged 6–23 months, pregnant women, those with chronic medical conditions, older adults aged 65 years and above).